drugset / Trial / NCT02307591

Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)

NCT02307591

Phase 2/3 Withdrawn Emergency NGO Onlus
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of amiodarone in the treatment of patients afflicted with Ebola virus disease.

Timeline

Start
2014-12
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiodarone Small molecule 5 mg/kg Intravenous
Subject Amiodarone Small molecule 20 mg/kg Intravenous
Subject Amiodarone Small molecule 30 mg/kg Intravenous
Subject Amiodarone Small molecule 200 mg Intravenous